Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2017-11-01

Clinical Trial Update: Endothelial Cell Specific Molecule-1 (ESM-1): a Novel Biomarker for ARDS Endothelial Injury

View source ↗

Summary

This clinical trial update describes investigating whether endothelial cell–specific molecule-1 (ESM-1) levels correlate with prognosis in patients with acute r…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Jingyuan,Xu | Conditions: Evaluate the Correlation Between the Level of ESM-1 and the Prognosis of the Patients With ARDS | Status: UNKNOWN